Shizuoka

Data cited: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years 1990-2016. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018.   The Global Burden of Disease Study 2016 (GBD 2016), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 195 countries and territories and at the subnational level for a subset of countries. Estimates for deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and incidence for 29 cancer groups by age and sex for 1990-2016 are available from the GBD Results Tool. Files available in this record are the web tables published in JAMA Oncology in June 2018 in "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 29 Cancer Groups, 1990 to 2016."

These Community Mobility Reports aim to provide insights into what has changed in response to policies aimed at combating COVID-19. The reports chart movement trends over time by geography, across different categories of places such as retail and recreation, groceries and pharmacies, parks, transit stations, workplaces, and residential.

We define our day as midnight-to-midnight, Pacific time. Cities represent usage in greater metropolitan areas and are stably defined during this period. In many countries/regions and cities, relative volume has increased since January 13th, consistent with normal, seasonal usage of Apple Maps. Day of week effects are important to normalize as you use this data. Data that is sent from users’ devices to the Maps service is associated with random, rotating identifiers so Apple doesn’t have a profile of your movements and searches. Apple Maps has no demographic information about our users, so we can’t make any statements about the representativeness of our usage against the overall population. This information will be available for a limited time during the COVID‑19 pandemic.